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The many challenges of multimorbidity
The dramatic rise in long-term conditions (LTCs) 
represents a major challenge for individuals, families, and 
healthcare systems worldwide [1]. Due to the scale of 
this rise, the management of patients with LTCs largely 
falls within the domain of primary rather than secondary 
care, at least in countries with well-developed primary 
care systems. For example, in the UK, which has a com-
prehensive primary care system based around general 
practice (trained family physicians working in multidisci-
plinary teams) and funded by the National Health Service 
(NHS), primary care contacts account for around 90% 
of the total activity of the NHS, and patients with LTCs 
account for 80% of general practice consultations [2]. 
Effective primary care and community-based manage-
ment of people with LTCs is thus a top priority [2–6].
Multimorbidity (usually defi ned as the co-existence of 
two or more LTCs in an individual, though defi nitions 
vary) [7] is the norm rather than the exception for people 
with LTCs in the UK [8, 9] and elsewhere [10–12], and 
is related to both increasing age [13] and socio-economic 
deprivation [9]. Multimorbidity cuts across the vertical 
paradigms in which most health research is envisaged 
and funded [14]. Patients with multimorbidity are usu-
ally excluded from such research and thus the nature and 
complex needs of such patients are not well understood 
and the evidence- base on which to treat them is lacking 
[14–17].
Our knowledge and understanding of variations in 
the effect of multimorbidity on issues such as illness bur-
den [18], quality of life and well-being [19], treatment 
burden [20], and unmet needs [9], remain poor. Further-
more, studies on the quality of primary care [21, 22] and 
other community-based resources [23] and their impact 
on patients with multimorbidity are also rare.
Where should we begin? 
Despite the high prevalence of multimorbidity and 
the key role of primary care in its management, the 
evidence-base for interventions in this group in primary 
care is extremely limited [24]. More research on inter-
ventions in primary care for people with multimorbidity 
is urgently needed, but what should these interventions 
be based on? How do we know what is likely to help?
An important precursor to developing effective inter-
ventions is knowledge of the effects of multimorbidity 
over time and the factors which infl uence these effects. 
Prospective cohort studies are the most robust method of 
studying and describing the natural history and devel-
opment of morbidity and also for the development and 
implementation of prognostic models [25, 26]. However, 
a recent systematic review of prospective cohort stud-
ies of multimorbidity in primary care identifi ed only a 
handful of studies [27]. Although the studies identifi ed 
provide some useful information, they also demonstrate 
the signifi cant gaps that exist in knowledge. 
To plan future healthcare services and treatment 
guidelines for those with multimorbidity we must 
better understand the personal experience, treatment, 
and health service use, and the psychological, physical, 
and social factors that infl uence multimorbidity. Fortu-
nately, several new large cohort studies are underway in 
Canada and Europe, which will yield important infor-
mation in the years to come [28–30].
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The MALT study
We have also been working to establish such a cohort 
in Scotland, a devolved nation within the UK that is 
responsible for its own health budget and for how NHS 
services are confi gured. The Scottish Multiple And 
Long-Term conditions (MALT) cohort study aims to 
support essential research on issues such as:
The natural history and impact of multimorbidity  •
(including predictors of poor outcomes)
The relationships between multimorbidity and the  •
accessibility, use, and costs of primary care, other health 
and social care services and community-based resources
The infl uence of multimorbidity on patient engagement,  •
activation, and self management
The process and outcome of clinical encounters over  •
time and factors promoting or hindering the develop-
ment of preventive (anticipatory) patterns of care 
The quality and safety of care in such patients •
The components and combinations of primary care  •
and other supports that work best in multimorbidity.
Additionally, future linked studies could include complex 
interventions and genetic and environmental predictors 
of morbidity and poor outcomes in multimorbidity. The 
framework for the MALT study is shown in Figure 1.
In developing the MALT study (see Figure 2), we 
have been assisted by a 2-year international Visiting 
Professor Award ( J.G.) and funding for two part-time 
post-doctoral researchers by the Scottish School of 
Primary Care. Work to date has included a systematic 
review [27], ongoing secondary analysis of a nation-
ally representative cross-sectional primary care database 
of 1.8 million people with up to 40 LTCs, and iden-
tifi cation of existing longitudinal data amendable to 
secondary analysis. A series of stakeholder meetings 
have also been held with affi liated MALT researchers in 
Scotland, qualitative interviews with senior policy 
makers and NHS strategists, and a 1-day international 
workshop with experts in multimorbidity research from 
Canada, Australia, Ireland, England, and Scotland.
Key areas of discussion in these meetings included 
defi ning the primary aims of the prospective cohort 
study, how best to defi ne and measure multimorbid-
ity, and whether to include a wide range of conditions 
in order to be as inclusive as possible or to focus on a 
limited number of LTCs of key public health concern. 
Consideration was also given as to how best to cap-
ture the required data, including what can be measured 
from routinely collected data, data linkage issues, and 
what new data need to be collected by direct methods, 
including survey methods and longitudinal qualitative 
interviews. The importance of international collabora-
tion was also emphasized so that studies carried out in 
one country might have relevance in other countries, 
with the possibility of linked cohorts to aid our global 
understanding of the common issues in multimorbidity 
and its management. 
Central to all future work on multimorbidity must be 
a focus on the patient as a functioning person, integrated 
Quality and volume
of clinical care
(technical and
interpersonal)
A simple representation of the relationship between
disease severity, symptoms and quality of life
Health-
related
quality of life,
well-being
and mortality
Personal
resources
Social and material
environment in which
people’s lives shape
the relationships
Treatment
burden
Access to and
quality of
community
resources
Severity of
disease and
symptoms
experienced
by people
with multiple
morbidity
Relationships develop over time
Figure 1 Framework for the Scottish Multiple And Long-Term conditions (MALT) prospective, cohort study.
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within a family and a community. Nowhere in medicine 
is person-centred care more appropriate than in individu-
als with multimorbidity, with their complex physical and 
psychosocial needs [9, 10, 13, 31], and yet there has been 
surprisingly little research on this in this group in terms 
of patients’ expectations, the doctor–patient relationship, 
the process and outcomes of clinical encounters, and the 
importance of human aspects of care such as practitioner 
empathy [32].
The need for prospective cohort studies
In conclusion, multimorbidity now represents the 
norm not the exception in individuals with LTCs, and 
is arguably the biggest challenge facing healthcare sys-
tems globally. Strong primary care systems are required 
to deliver the holistic, person-centred care that the 
complexity of multimorbidity demands. However, the 
evidence-based for effective interventions in multimor-
bidity in primary care is weak, and prospective cohort 
studies are required to gain a better understanding of 
the natural history and trajectory of multimorbidity in 
different populations, and how healthcare and other 
services can best be confi gured to meet the needs of 
people with multimorbidity. Given the vertical para-
digm that currently still dominates healthcare, medical 
education, and research, there is much work that needs 
to be done.
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Figure 2 Research programme of the Scottish Multiple And Long-Term conditions (MALT) prospective, cohort study. MM, multimorbidity.
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